前列腺癌基因组亚型中的雄激素受体信号传导
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.
作者信息
Hussein Mohamed Ali, Munirathinam Gnanasekar
机构信息
Department of Pharmaceutical Services, Children's Cancer Hospital Egypt, Cairo 57357, Egypt.
Department of Biology, School of Sciences and Engineering, American University in Cairo, New Cairo 11835, Egypt.
出版信息
Cancers (Basel). 2023 Oct 13;15(20):4969. doi: 10.3390/cancers15204969.
Abstract
Prostate cancer (PCa) constitutes a significant cause of mortality, with over 37,000 new deaths each year [...].
摘要
前列腺癌（PCa）是一个重要的死亡原因，每年有超过37000例新的死亡病例[……]。
相似文献
1
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.前列腺癌基因组亚型中的雄激素受体信号传导
Cancers (Basel). 2023 Oct 13;15(20):4969. doi: 10.3390/cancers15204969.
2
Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth.雄激素受体（AR）与Wnt信号通路之间的相互作用促进去势抵抗性前列腺癌的生长。
Onco Targets Ther. 2020 Sep 18;13:9257-9267. doi: 10.2147/OTT.S245861. eCollection 2020.
3
Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.雄激素受体（AR）在前列腺癌细胞死亡中的阳性和阴性作用，包括细胞凋亡、失巢凋亡、侵入、坏死和自噬性细胞死亡。
Cancer Treat Rev. 2014 Feb;40(1):31-40. doi: 10.1016/j.ctrv.2013.07.008. Epub 2013 Aug 7.
4
Non-canonical androgen signaling pathways and implications in prostate cancer.非经典雄激素信号通路及其在前列腺癌中的意义。
Biochim Biophys Acta Mol Cell Res. 2022 Dec;1869(12):119357. doi: 10.1016/j.bbamcr.2022.119357. Epub 2022 Sep 11.
5
Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.80 岁及 90 岁以上局限性前列腺癌患者一线雄激素剥夺治疗的生存结果。
Eur Urol Focus. 2018 Dec;4(6):834-841. doi: 10.1016/j.euf.2017.01.017. Epub 2017 Feb 11.
6
Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway.超生理水平的雄激素通过Src-Akt信号通路诱导人前列腺癌细胞发生细胞衰老。
Mol Cancer. 2014 Sep 12;13:214. doi: 10.1186/1476-4598-13-214.
7
Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling.丛生梭菌代谢物通过雄激素受体信号触发前列腺癌进展。
J Microbiol Immunol Infect. 2023 Apr;56(2):246-256. doi: 10.1016/j.jmii.2022.12.009. Epub 2023 Jan 2.
8
Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer.表观遗传学与促进前列腺癌雄激素信号转导之间的串扰。
Vitam Horm. 2023;122:253-282. doi: 10.1016/bs.vh.2022.11.007. Epub 2022 Dec 29.
9
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo.雄激素受体信号在去势抵抗性前列腺癌中改变了体内的高极化丙酮酸向乳酸的转化和乳酸水平。
Mol Imaging Biol. 2019 Feb;21(1):86-94. doi: 10.1007/s11307-018-1199-6.
10
Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression.基因组改变与雄激素受体信号在前列腺癌发生发展过程中的相互作用。
Horm Cancer. 2013 Apr;4(2):61-9. doi: 10.1007/s12672-013-0131-4. Epub 2013 Jan 10.
引用本文的文献
1
Strategic Advances in Combination Therapy for Metastatic Castration-Sensitive Prostate Cancer: Current Insights and Future Perspectives.转移性去势敏感性前列腺癌联合治疗的策略进展：当前见解与未来展望
Cancers (Basel). 2024 Sep 18;16(18):3187. doi: 10.3390/cancers16183187.
本文引用的文献
1
The androgen receptor.雄激素受体。
Vitam Horm. 2023;123:439-481. doi: 10.1016/bs.vh.2023.01.001. Epub 2023 Aug 17.
2
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.前列腺癌基因组亚型中的雄激素受体信号传导
Cancers (Basel). 2021 Jun 30;13(13):3272. doi: 10.3390/cancers13133272.
4
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.前列腺癌中的雄激素受体：结构、配体及剪接变体对治疗的影响
Biomedicines. 2020 Oct 15;8(10):422. doi: 10.3390/biomedicines8100422.
5
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.PI3K-AKT-mTOR 通路与前列腺癌：AR、MAPK 和 WNT 信号的十字路口。
Int J Mol Sci. 2020 Jun 25;21(12):4507. doi: 10.3390/ijms21124507.
6
Significance of the TMPRSS2:ERG gene fusion in prostate cancer.TMPRSS2:ERG 基因融合在前列腺癌中的意义。
Mol Med Rep. 2017 Oct;16(4):5450-5458. doi: 10.3892/mmr.2017.7281. Epub 2017 Aug 18.
7
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.前列腺癌中对雄激素受体抑制剂耐药的新机制
Nat Rev Cancer. 2015 Dec;15(12):701-11. doi: 10.1038/nrc4016. Epub 2015 Nov 13.
8
MYC, Metabolism, and Cancer.MYC、代谢与癌症。
Cancer Discov. 2015 Oct;5(10):1024-39. doi: 10.1158/2159-8290.CD-15-0507. Epub 2015 Sep 17.
9
Androgen receptors in hormone-dependent and castration-resistant prostate cancer.雄激素受体在激素依赖性和去势抵抗性前列腺癌中的作用。
Pharmacol Ther. 2013 Dec;140(3):223-38. doi: 10.1016/j.pharmthera.2013.07.003. Epub 2013 Jul 13.
10
Molecular biology of the Ets family of transcription factors.转录因子Ets家族的分子生物学
Gene. 2003 Jan 16;303:11-34. doi: 10.1016/s0378-1119(02)01156-3.
Zotero 插件